Clearance of the high intestinal 18 F-FDG uptake associated with metformin after stopping the drug

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 5, 2010, Pages 1011-1017

  Özülker, Tamer ^a,b   Özülker, Filiz ^a   Mert, Meral ^a   Özpaçacı, Tevfik ^a  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Darü afaka Mah Gazeteciler Sitesi   (Turkey)

Author keywords

Antidiabetic; Bowel uptake; Metformin

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; ISOPHANE INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG CLEARANCE; DRUG POTENTIATION; DRUG UPTAKE; DUODENUM; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GLUCOSE BLOOD LEVEL; HUMAN; JEJUNUM; LARYNX CARCINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY CARCINOMA; PATIENT REFERRAL; RECTUM CANCER; SCORING SYSTEM; SMALL INTESTINE;

EID: 77952289793     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1330-7     Document Type: Article

References (20)

1. A Bischof Delalove RL Wahl 1995 How high a level of FDG abdominal activity is considered normal? J Nucl Med 36 Suppl 106P Abstract
2. K Nakada SJ Fisher RS Brown RL Wahl 1999 FDG uptake in the gastrointestinal tract: can it be reduced? J Nucl Med 40 22 23
3. A Stahl WA Weber N Avril M Schwaiger 2000 Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen Nuklearmedizin 39 241 245 1:CAS:528:DC%2BD3MXjtV2jug%3D%3D 11189901 (Pubitemid 32039700)
4. H Jadvar RB Schambye GM Segall 1999 Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose Clin Nucl Med 24 965 967 10.1097/00003072-199912000-00012 1:STN:280:DC%2BD3c%2FmtV2htQ%3D%3D 10595478
5. E Gontier E Fourme M Wartski, et al. 2008 High and typical 18F-FDG bowel uptake in patients treated with metformin Eur J Nucl Med Mol Imaging 35 95 99 10.1007/s00259-007-0563-6 1:CAS:528:DC%2BD2sXhsVSmtLnF 17786437 (Pubitemid 350234148)
6. F Miraldi H Vesselle PF Faulhaber LP Adler GP Leisure 1998 Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer Clin Nucl Med 23 3 7 10.1097/00003072-199801000-00002 1:STN:280:DyaK1c7gsFWltA%3D%3D 9442955 (Pubitemid 28069052)
7. CJ Bailey KJ Mynett T Page 1994 Importance of the intestine as a site of metformin-stimulated glucose utilization Br J Pharmacol 112 671 675 1:CAS:528:DyaK2cXksV2rtLY%3D 8075887 (Pubitemid 24172918)
8. CJ Bailey RC Turner 1996 Metformin N Engl J Med 334 574 579 10.1056/NEJM199602293340906 1:CAS:528:DyaK28XhvVCjs74%3D 8569826 (Pubitemid 26066132)
9. T Ikeda K Iwata H Murakami 2000 Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine Biochem Pharmacol 59 887 890 10.1016/S0006-2952(99)00396-2 1:CAS:528:DC%2BD3cXpsVWmug%3D%3D 10718348 (Pubitemid 30081713)
10. C Wilcock CJ Bailey 1991 Reconsideration of inhibitory effect of metformin on intestinal glucose absorption J Pharm Pharmacol 43 120 121 1:CAS:528:DyaK3MXhtlGru78%3D 1672896
11. C Wilcock CJ Bailey 1990 Sites of metformin-stimulated glucose metabolism Biochem Pharmacol 39 1831 1834 10.1016/0006-2952(90)90136-9 1:CAS:528:DyaK3cXksFagsLs%3D 2111705 (Pubitemid 20166641)
12. C Wilcock CJ Bailey 1994 Accumulation of metformin by tissues of the normal and diabetic mouse Xenobiotica 24 49 57 10.3109/00498259409043220 1:CAS:528:DyaK2cXhsFaqsbo%3D 8165821 (Pubitemid 24058005)
13. CJ Bailey C Wilcock C Day 1992 Effect of metformin on glucose metabolism in the splanchnic bed Br J Pharmacol 105 1009 1013 1:CAS:528:DyaK38Xit1yjs7k%3D 1504710
14. L Pénicaud Y Hitier P Ferré J Girard 1989 Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine Biochem J 262 881 885 2686622 (Pubitemid 19225163)
15. CJ Bailey C Wilcock JH Scarpello 2008 Metformin and the intestine Diabetologia 51 1552 1553 10.1007/s00125-008-1053-5 1:STN:280: DC%2BD1cvnslensw%3D%3D 18528677
16. W Wang KL Guan 2009 AMP-activated protein kinase and cancer Acta Physiol (Oxf) 196 55 63 10.1111/j.1748-1716.2009.01980.x 1:CAS:528:DC%2BD1MXlt1KrtL4%3D
17. P Sanz 2008 AMP-activated protein kinase: structure and regulation Curr Protein Pept Sci 9 478 492 10.2174/138920308785915254 1:CAS:528: DC%2BD1cXhtFKnur3O 18855699
18. AC Santomauro Júnior MR Ugolini AT Santomauro RP Souto 2008 Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome Arq Bras Endocrinol Metabol 52 120 125 18345405
19. FN Roy S Beaulieu L Boucher I Bourdeau C Cohade 2009 Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients J Nucl Med 50 178 183 10.2967/jnumed.108.056283 19164226
20. S Yasuda W Takahashi S Takagi H Fujii M Ide A Shohtsu 1998 Factors influencing physiological FDG uptake in the intestine Tokai J Exp Clin Med 23 241 244 1:STN:280:DyaK1MzksFSluw%3D%3D 10418728